1-5 of 5
Iris L. van Staveren
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

VAV3 and its binding proteins SIAH2 and EZH2 predict tamoxifen resistance in metastatic breast carcinomas

Free
Maurice P. Jansen, John A. Foekens, Iris L. Van Staveren, Kirsten Ritstier, Anieta M. Sieuwerts, Marion E. Meijer-Van Gelder, Maxime P. Look, Henk Portengen, Lambert C. Dorssers, Jan G. Klijn, Els M. Berns
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 511–512.
Published: 01 May 2005
View articletitled, VAV3 and its binding proteins SIAH2 and EZH2 predict tamoxifen resistance in metastatic breast carcinomas
Journal Articles

A gene signature that predicts platinum-based chemotherapy resistance in ovarian cancer patients

Free
Jozien Helleman, Maurice P. Jansen, Paul N. Span, Iris L. Van Staveren, Leon F. Massuger, Marion E. Meijer-Van Gelder, Fred C. Sweep, Patricia C. Ewing, Maria E. Van der Burg, Gerrit Stoter, Kees Nooter, Els M. Berns
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 389.
Published: 01 May 2005
View articletitled, A gene signature that predicts platinum-based chemotherapy resistance in ovarian cancer patients
Journal Articles

Complete Sequencing of TP53 Predicts Poor Response to Systemic Therapy of Advanced Breast Cancer

Available to Purchase
Els M. J. J. Berns, John A. Foekens, Rolf Vossen, Maxime P. Look, Peter Devilee, Sonja C. Henzen-Logmans, Iris L. van Staveren, Wim L. J. van Putten, Mats Inganäs, Marion E. Meijer-van Gelder, Cees Cornelisse, Cassandra J. C. Claassen, Henk Portengen, Bert Bakker, Jan G. M. Klijn
Journal: Cancer Research
Cancer Res (2000) 60 (8): 2155–2162.
Published: 01 April 2000
View articletitled, Complete Sequencing of TP53 Predicts Poor Response to Systemic Therapy of Advanced Breast Cancer
Open the PDF for Complete Sequencing of TP53 Predicts Poor Response to Systemic Therapy of Advanced Breast Cancer in another window
Journal Articles

c-myc Amplification Is a Better Prognostic Factor than HER2/neu Amplification in Primary Breast Cancer

Available to Purchase
Els M. J. J. Berns, Jan G. M. Klijn, Wim L. J. van Putten, Iris L. van Staveren, Henk Portengen, John A. Foekens
Journal: Cancer Research
Cancer Res (1992) 52 (5): 1107–1113.
Published: 01 March 1992
View articletitled, c-myc Amplification Is a Better Prognostic Factor than HER2/neu Amplification in Primary Breast Cancer
Open the PDF for c-myc Amplification Is a Better Prognostic Factor than HER2/neu Amplification in Primary Breast Cancer in another window
Journal Articles

Sporadic Amplification of the Insulin-like Growth Factor 1 Receptor Gene in Human Breast Tumors

Available to Purchase
Els M. J. J. Berns, Jan G. M. Klijn, Iris L. van Staveren, Henk Portengen, John A. Foekens
Journal: Cancer Research
Cancer Res (1992) 52 (4): 1036–1039.
Published: 01 February 1992
View articletitled, Sporadic Amplification of the Insulin-like Growth Factor 1 Receptor Gene in Human Breast Tumors
Open the PDF for Sporadic Amplification of the Insulin-like Growth Factor 1 Receptor Gene in Human Breast Tumors in another window